Skip to main content

Advertisement

Table 3 Results of initial LFT for viral hepatitis cases using laboratory-specific criteria for abnormality

From: Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort

  Case No. ALT AST Bilirubin ALP GGT Albumin Globulin Total Protein Repeat LFT Country of Origin (prevalence of viral hepatitis)
HBV 1 High* High Normal Normal High Normal Normal High Abnormal Kenya (High)
  2 Normal Normal High Normal Normal High Low Normal Abnormal UK (Low)
  3 High Normal Normal Normal High Normal Normal Normal Abnormal Pakistan (High)
  4 High* High High Normal High Normal Normal High Abnormal India (High)
  5 High* High Normal Normal Normal Normal Normal Normal Abnormal Malaysia (High)
  6 High* No result No result No result Normal Normal Normal Normal Abnormal UK (Low)
  7 Normal Normal Normal Normal Normal Normal High High Abnormal Kenya (High)
  8 No result High Normal High No result Normal No result No result Abnormal Iraq (High)
  9 Normal No result High Normal No result Normal No result No result Incomplete** Malta (High)
HCV 1 High Normal Normal Normal High Normal Normal Normal Incomplete Pakistan (High)
  2 High* High Normal Normal Normal Normal Normal High Abnormal Hong Kong (High)
  3 Normal No result Normal Normal High Normal No result No result Abnormal Jamaica (High)
  4 High* High Normal Normal Normal Normal Normal Normal Abnormal Somalia (High)
  1. * Denotes where ALT values were greater than twice the upper limit of normal.
  2. ** Repeat test available for AST and GGT only, both of which were normal.
  3. ALT: Alanine aminotransferase;
  4. AST: Aspartate aminotransferase;
  5. ALP: Alkaline phosphatase;
  6. GGT: Gamma-glutamyltransferase;
  7. HBV: Hepatitis B;
  8. HCV: Hepatitis C.